Zeilmaker-Roest, Gerdien
de Vries-Rink, Christine
van Rosmalen, Joost
van Dijk, Monique
de Wildt, Saskia N.
Knibbe, Catherijne A. J.
Koomen, Erik
Jansen, Nicolaas J. G.
Kneyber, Martin C. J.
Maebe, Sofie
Van den Berghe, Greet
Haghedooren, Renata
Vlasselaers, Dirk
Bogers, Ad J. J. C.
Tibboel, Dick
Wildschut, Enno D.
Funding for this research was provided by:
ZonMw (836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016, 836041016)
Stichting Vrienden van het Sophia (S16–08, S16–08, S16–08, S16–08, S16–08, S16–08, S16–08, S16–08)
Methusalem Programme from the Flemish Goverment (METH/14/06)
Horizon 2020 Framework Programme (AdvG-2017-785809)
Article History
Received: 26 January 2024
Accepted: 7 April 2024
First Online: 30 April 2024
Declarations
:
: The study was approved by the Erasmus MC Medical Ethics Committee and was registered in the Dutch trial registry under the code NTR5448 as well at the Central Committee on Research Involving Human Subjects (NL 53085.078.15), EudraCT (2015-001835-20-NL/BE), and clinicaltrials.gov (identifier: NCT05853263). Parents or legal guardians of the participating children provided written informed consent prior to any study procedures. The study protocol is published in <i>Trials</i> and available online [].
: Not applicable.
: The authors declare that they have no competing interests.